Cargando…
Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells
The presence of cancer stem cells (CSCs) or tumor-initiating cells can lead to cancer recurrence in a permissive cell–microenvironment interplay, promoting invasion in glioblastoma (GBM) and neuroblastoma (NB). Extracellular matrix (ECM) small leucine-rich proteoglycans (SLRPs) play multiple roles i...
Autores principales: | Farace, Cristiano, Oliver, Jaime Antonio, Melguizo, Consolacion, Alvarez, Pablo, Bandiera, Pasquale, Rama, Ana Rosa, Malaguarnera, Giulia, Ortiz, Raul, Madeddu, Roberto, Prados, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521885/ https://www.ncbi.nlm.nih.gov/pubmed/26230845 http://dx.doi.org/10.1371/journal.pone.0134111 |
Ejemplares similares
-
Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression
por: Perazzoli, Gloria, et al.
Publicado: (2015) -
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
por: Melguizo, Consolación, et al.
Publicado: (2012) -
Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications
por: Ortiz, Raúl, et al.
Publicado: (2021) -
Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies
por: Kelemen, Linda E, et al.
Publicado: (2008) -
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
por: Oliver, Jaime Antonio, et al.
Publicado: (2014)